Evidence map›Paper›PMID 41820985›Full record

ReviewMolecular cancer2026

The multifaceted functions of selective autophagy in cancer: molecular basis, consequences, and clinical prospects.

Mingyang Jiang, Ke Zhang, Meng Li, Yu Tian, Tao Wang, Raquel Alarcón Rodríguez, Zhanghui Lin, Jinfeng Meng, Chenghao Li, Zheng Wang and 10 more

Erratum issuedAbstract readReview
In one paragraph

Review in Molecular cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Mingyang Jiang *Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China.
Ke Zhang *Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China.
Meng Li *Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Yu TianResearch Center, the Huizhou Central People's Hospital, Guangdong Medical University, Huizhou, Guangdong, 516008, China.
Tao WangDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China.
Raquel Alarcón RodríguezFaculty of Health Sciences, University of Almeria, Carretera Sacramento S/N, La Canada, Almería, 04120, Spain.
Zhanghui LinGuangxi Medical University, Nanning, Guangxi, 530021, China.
Jinfeng MengGuangxi Medical University, Nanning, Guangxi, 530021, China.
Chenghao LiGuangxi Medical University, Nanning, Guangxi, 530021, China.
Zheng WangGuangxi Medical University, Nanning, Guangxi, 530021, China.
Sichang WuGuangxi Medical University, Nanning, Guangxi, 530021, China.
Yunfei CaiGuangxi Medical University, Nanning, Guangxi, 530021, China.
Wenyang ZhangGuangxi Medical University, Nanning, Guangxi, 530021, China.
Rui GuoGuangxi Medical University, Nanning, Guangxi, 530021, China.
Yao LiuGuangxi Medical University, Nanning, Guangxi, 530021, China.
Yuqi BaiNanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, 210019, China.
Guichuan Lai *Department of Health Statistics, School of Public Health, Chongqing Medical University, Chongqing, 400016, China. 2020111425@stu.cqmu.edu.cn.
Chengcheng Zhang *Department of Medical Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. 18117022797@163.com.
Zhandong Bo *Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China. drrbozhandong@126.com.
Ruqiong Wei *Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China. weiruqiongxibanya@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selective autophagy is a critical cellular process in eukaryotic cells, characterized by the targeted degradation of specific organelles and proteins. This intricate mechanism plays a vital role in maintaining cellular homeostasis and has significant implications in the pathogenesis and progression of various diseases, notably cancer. Recent studies have highlighted the dual role of selective autophagy in cancer, acting both as a suppressor in the early stages and potentially facilitating progression in later stages. The complexity of selective autophagy, particularly in the context of oncogenesis, presents unique challenges. This review focuses on the molecular mechanisms underlying selective autophagy, its impact on cancer development and progression, and the challenges in leveraging this process for therapeutic interventions. We discuss the interplay between autophagy and cancer, examining how alterations in autophagic pathways contribute to tumorigenesis and the resistance of cancer cells to therapy. Additionally, we explore the potential of targeting selective autophagy pathways as a novel approach in cancer treatment, considering the challenges and prospects of such strategies.

Indexed as

AutophagyNeoplasmsAnimalsCell Transformation, NeoplasticHumansSignal TransductionCellular HomeostasisEukaryotic CellsMolecular MechanismsOncogenesisOrganelle DegradationSelective Autophagy

Identifiers

PMID41820985
PMCPMC12983598

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.